Marine Drugs (Mar 2023)

Fibrin and Marine-Derived Agaroses for the Generation of Human Bioartificial Tissues: An Ex Vivo and In Vivo Study

  • Olimpia Ortiz-Arrabal,
  • Ainhoa Irastorza-Lorenzo,
  • Fernando Campos,
  • Miguel Ángel Martín-Piedra,
  • Víctor Carriel,
  • Ingrid Garzón,
  • Paula Ávila-Fernández,
  • María José de Frutos,
  • Emilio Esteban,
  • Javier Fernández,
  • Agustín Janer,
  • Antonio Campos,
  • Jesús Chato-Astrain,
  • Miguel Alaminos

DOI
https://doi.org/10.3390/md21030187
Journal volume & issue
Vol. 21, no. 3
p. 187

Abstract

Read online

Development of an ideal biomaterial for clinical use is one of the main objectives of current research in tissue engineering. Marine-origin polysaccharides, in particular agaroses, have been widely explored as scaffolds for tissue engineering. We previously developed a biomaterial based on a combination of agarose with fibrin, that was successfully translated to clinical practice. However, in search of novel biomaterials with improved physical and biological properties, we have now generated new fibrin-agarose (FA) biomaterials using 5 different types of agaroses at 4 different concentrations. First, we evaluated the cytotoxic effects and the biomechanical properties of these biomaterials. Then, each bioartificial tissue was grafted in vivo and histological, histochemical and immunohistochemical analyses were performed after 30 days. Ex vivo evaluation showed high biocompatibility and differences in their biomechanical properties. In vivo, FA tissues were biocompatible at the systemic and local levels, and histological analyses showed that biointegration was associated to a pro-regenerative process with M2-type CD206-positive macrophages. These results confirm the biocompatibility of FA biomaterials and support their clinical use for the generation of human tissues by tissue engineering, with the possibility of selecting specific agarose types and concentrations for applications requiring precise biomechanical properties and in vivo reabsorption times.

Keywords